The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

HRTX FINANCIAL STATEMENTS

Heron Therapeuti — balance sheet, income statement and cash flow trends

HRTXHeron Therapeuti

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue151.2 M $Gross Profit105.9 M $ · 70%Operating Income-10.9 M $ · -7%Pre-tax Income-34 M $ · -23%Net Income to Owners-34 M $ · -23%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue151.2 M $+1.0%
Gross Profit105.9 M $-5.2%
Operating Income-10.9 M $-981.8%
EBITDA-27.8 M $-504.5%
Net Income to Owners-34 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets252.3 M
  • Equity6.9 M $3%
  • Current Liabilities92.1 M $37%
  • Long-term Liabilities153.2 M $61%

Key Figures

YoY change
Total Assets252.3 M $+8.7%
Total Liabilities245.4 M $-5.4%
Total Equity6.9 M $—
Cash & ST Investments42.7 M $+5.0%
Total Debt148.4 M $-16.1%
Net Debt127.6 M $-20.3%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-10 M-5 M0-11.6 M $Operating2.2 M $Investing13.6 M $Financing4.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-11.6 M $—
Capital Expenditures529 K $-61.8%
Free Cash Flow-12.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on HRTX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.